Leadership

The foundation’s leaders come from a broad range of backgrounds and have a diversity of expertise and experience that spans science and technology, medicine, public policy, education, communications, law, and business. Our leaders are guided by the foundation’s mission to create a world in which every person has the opportunity to live a healthy, productive life.

We are governed by a board, which in 2022 was expanded to include the CEO and five independent experts. The members of the board contribute diverse perspectives, backgrounds, and expertise to help guide and strengthen the foundation's governance, strategic direction, operations, financial planning, and overall performance. Click here to meet our board.

Meet our leaders

Meet our leaders

Divisions
Program strategies
1 - 18of 50
New Results
  • President, Global Health
    Trevor Mundel leads the foundation’s efforts to develop high-impact interventions against the leading causes of death and disability in developing countries.
  • Director, Integrated Development
    Dr. Dan Hartman leads a team that provides technical expertise in product development to other foundation teams and their partners.
  • Director, Strategy, Planning and Management
    Dr. Toni Hoover leads a team that supports the programs and functions with business strategy and operations, portfolio and project management, and engagement with industry and product development partners.
  • Director, Discovery & Translational Sciences
    Chris Karp leads the team whose mission is to catalyze innovation for the discovery and translation of transformative solutions to global health and development inequity.
  • Director, Pneumonia
    Keith Klugman leads the foundation’s work to reduce child deaths from pneumonia, neonatal sepsis, and meningitis.
  • Director, Vaccine Development and Neglected Tropical Diseases
    Katey Einterz Owen, Ph. D. leads efforts in controlling, eliminating, and eradicating the diseases of the London Declaration on Neglected Tropical Diseases, which collectively put at risk more than one billion people in the world.
  • Director, HIV & TB Delivery
    Yogan Pillay leads the foundation’s efforts to strengthen TB & HIV Program Delivery globally.
  • Director, TB & HIV Research and Development
    Dr. Nina Russell oversees the foundation’s investments in vaccine and drug development to prevent and treat tuberculosis (TB) and HIV.
  • Director, Malaria; Director, Institute for Disease Modeling
    Philip Welkhoff has led the foundation’s Malaria program since 2018 and has concurrently led the Institute for Disease Modeling (IDM) since 2021.
  • Deputy Director, Reproductive Health Technologies
    Dr. Sharon Achilles leads the foundation’s efforts in drug discovery and innovative approaches to improving reproductive and sexual health, with a focus on women in low-resource settings.
  • Deputy Director, HIV and Tuberculosis
    Pervin Anklesaria leads the HIV vaccines and biologics prevention efforts for the foundation’s HIV team.
  • Deputy Director, Partnership Experience
    Rob Baker leads a team that works to streamline existing or implement new technologies to improve the experience of external partners who collaborate on research projects with the Institute for Disease Modeling (IDM) or independently use IDM’s modeling tools.
  • Deputy Director, Translational Sciences
    Fran Berlioz-Seux leads a team that focuses on accelerating the translation of scientific discoveries to practical solutions that address global health inequity across the foundation’s work.
  • Deputy Director, Vaccine Development & Surveillance – Modelling and Pathogen Genomic Sequencing
    David Blazes leads the foundations work on global burden of disease modelling and pathogen genomic sequencing. 
  • Deputy Director, Technology Diffusion
    Zameer Brey leads the strategic coordination of the foundation’s approach to the equitable and safe use of artificial intelligence (AI) to advance equity and global health and development outcomes.
  • Deputy Director, Eradication and Elimination, Artificial Intelligence, and Frontiers in Modeling
    Guillaume Chabot-Couture leads disease elimination and eradication efforts at the Institute for Disease Modeling, focusing on polio eradication, malaria eradication, vaccine preventable disease control, neglected tropical diseases control, and disease eradication genomics.
  • Deputy Director, Vaccine Development & Surveillance – Surveillance and Epidemiology
    Scott Dowell, a pediatric infectious disease specialist by training, focuses on tracking the causes of global childhood mortality. and oversees the foundations work in epidemic and pandemic preparedness and response.
  • Deputy Director, Vaccine Development & Surveillance – Clinical Evaluation and HPV
    Peter Dull is a deputy director in Vaccine Development & Surveillance leading the Clinical domain and our work on Human Papilloma Virus.

More about the foundation

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we've created to address urgent issues in global health, global development, and education.

Ideas

Read the latest stories, research, and news from across the foundation and subscribe to our weekly newsletter, The Optimist.